COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,722 Articles (22,913 medRxiv, 8,809 bioRxiv)

Most recent first Previous |  Page 1671: Articles 16701-16710  | Next

Do post-COVID-19 patients need a second dose of vaccine?
Taubel, J., Spencer, C. S., Freier, A., Camilleri, D., Garitaonandia, I., Lorch, U.
10.1101/2021.04.09.21255200 — Posted: 2021-04-13
Increased serum thromboxane A2 and prostacyclin but lower complement C3 and C4 levels in COVID-19: associations with chest CT-scan anomalies and lowered peripheral oxygen saturation.
Al-Hakeim, H. K., Al-Hamami, S., Maes, M.
10.1101/2021.04.10.21255240 — Posted: 2021-04-13
The Balancing Role of Distribution Speed against Varying Efficacy Levels of COVID-19 Vaccines under Variants
Kim, D., Keskinocak, P., Pekgun, P., Yildirim, I.
10.1101/2021.04.09.21255217 — Posted: 2021-04-13
Integrative approach identifies SLC6A20 and CXCR6 as putative causal genes for the COVID-19 GWAS signal in the 3p21.31 locus
Kasela, S., Daniloski, Z., Jordan, T. X., tenOever, B. R., Sanjana, N. E., Lappalainen, T.
10.1101/2021.04.09.21255184 — Posted: 2021-04-13
COLI-NET: Fully Automated COVID-19 Lung and Infection Pneumonia Lesion Detection and Segmentation from Chest CT Images
Shiri, I., Arabi, H., Salimi, Y., Sanaat, A. H., Akhavanalaf, A., Hajianfar, G., Askari, D., Moradi, S., Mansouri, Z., Pakbin, M., Sandoughdaran, S., Abdollahi, H., Radmard, A. R., Rezaei-Kalantari, K., Ghelich Oghli, M., Zaidi, H.
10.1101/2021.04.08.21255163 — Posted: 2021-04-13
Assessment of the COVID-19 Vaccine Program: Impact of the No Mask Mandate Executive Order in the State of Texas
Iboi, E., Richardson, A. G., Ruffin, R.
10.1101/2021.04.08.21255156 — Posted: 2021-04-13
The allometric propagation of COVID-19 is explained by human travel
Tuladhar, R., Grigolini, P., Santamaria, F.
10.1101/2021.04.08.21255169 — Posted: 2021-04-13
Refining long-COVID by a prospective multimodal evaluation of patients with long-term symptoms related to SARS-CoV-2 infection
SCHERLINGER, M., Felten, R., Gallais, F., Nazon, C., Chatelus, E., Pijnenburg, L., Mengin, A., Gras, A., Vidailhet, P., Arnould-Michel, R., Bibi-triki, S., Carapito, R., Bahram, S., trouillet-assant, s., Perret, M., Belot, A., Arnaud, L., Gottenberg, J.-E., Fafi-Kremer, S., Sibilia, J.
10.1101/2021.04.08.21255167 — Posted: 2021-04-13
Compliance with Covid-19 measures: evidence from New Zealand
Kaine, G., Greenhalgh, S., Wright, V.
10.1101/2021.04.08.21255157 — Posted: 2021-04-13
Undergraduate student interest in healthcare career in the context of COVID-19 pandemic
Jo, S. Y., Li, J., Dewan, A., Cheng, Y.-C., Hou, H., Sebro, R. A.
10.1101/2021.04.11.438530 — Posted: 2021-04-12

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).